Voriconazole

Generic: Voriconazole

Labeler: Mckesson Corporation DBA SKY Packaginng
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive

Drug Facts

Product Profile

Brand Name Voriconazole
Generic Name Voriconazole
Labeler Mckesson Corporation DBA SKY Packaginng
Dosage Form TABLET
Routes
ORAL
Active Ingredients

VORICONAZOLE 200 mg/1

Identifiers & Regulatory

Product NDC 63739-008
Product ID 63739-008_2b9c5378-33d7-6d41-e063-6294a90a6f54
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA206181
Marketing Start 2016-05-31
Marketing End 2026-02-28

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 63739008
Hyphenated Format 63739-008

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name Voriconazole (source: ndc)
Generic Name Voriconazole (source: ndc)
Application Number ANDA206181 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 200 mg/1
source: ndc
Packaging
  • 3 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-008-33) / 10 TABLET in 1 BLISTER PACK
source: ndc

Packages (1)

Ingredients (1)

VORICONAZOLE (200 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2b9c5378-33d7-6d41-e063-6294a90a6f54", "openfda": {"nui": ["N0000175487", "M0002083", "N0000182141", "N0000182140", "N0000185504"], "unii": ["JFU09I87TR"], "rxcui": ["349434"], "spl_set_id": ["aa18d6fa-8a5c-4c69-b4db-6ae578165d7d"], "pharm_class_cs": ["Azoles [CS]"], "pharm_class_epc": ["Azole Antifungal [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]"], "manufacturer_name": ["Mckesson Corporation DBA SKY Packaginng"]}, "finished": true, "packaging": [{"sample": false, "description": "3 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-008-33)  / 10 TABLET in 1 BLISTER PACK", "package_ndc": "63739-008-33", "marketing_end_date": "20260228", "marketing_start_date": "20160531"}], "brand_name": "Voriconazole", "product_id": "63739-008_2b9c5378-33d7-6d41-e063-6294a90a6f54", "dosage_form": "TABLET", "pharm_class": ["Azole Antifungal [EPC]", "Azoles [CS]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]"], "product_ndc": "63739-008", "generic_name": "Voriconazole", "labeler_name": "Mckesson Corporation DBA SKY Packaginng", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Voriconazole", "active_ingredients": [{"name": "VORICONAZOLE", "strength": "200 mg/1"}], "application_number": "ANDA206181", "marketing_category": "ANDA", "marketing_end_date": "20260228", "marketing_start_date": "20160531"}